Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -316 | -166 | -1,488 | -1,180 | -1,021 |
| Depreciation Amortization | 16 | 9 | 55 | 44 | 35 |
| Other Working Capital | 172 | 100 | 445 | 199 | 123 |
| Other Operating Activity | 36 | 18 | 662 | 648 | 623 |
| Operating Cash Flow | $-93 | $-39 | $-327 | $-288 | $-240 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $0 | $0 | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1 | 1 | 29 | 24 | 0 |
| Debt Repayment | N/A | N/A | -17 | -17 | N/A |
| Common Stock Issued | 13 | 5 | 5 | N/A | N/A |
| Other Financing Activity | 73 | 35 | 310 | 275 | 235 |
| Financing Cash Flow | $87 | $41 | $327 | $282 | $235 |
| Beginning Cash Position | 6 | 6 | 6 | 6 | 6 |
| End Cash Position | 0 | 8 | 6 | 0 | 1 |
| Net Cash Flow | $-6 | $1 | $0 | $-6 | $-5 |
| Free Cash Flow | |||||
| Operating Cash Flow | -93 | -39 | -327 | -288 | -240 |
| Free Cash Flow | -93 | -39 | -327 | -288 | -240 |